Global Celiac Disease Treatment Pipeline Drug Evaluation Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery
Published on 09/07/2021| Code: MAR41115D| Category: Utilities| Total Pages: 130
Based on the Celiac Disease Treatment Pipeline Drug Evaluation market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Celiac Disease Treatment Pipeline Drug Evaluation market covered in Chapter 5:
Selecta Biosciences
Takeda Pharmaceuticals (PvP Biologics)
BioLineRx
ImmunogenX
Calypso Biotech
ImmusanT
Amgen
Sitari Pharma
Mayo Clinic
Innovate Biopharmaceuticals
Provention Bio
Zedira
Anokion
Bioniz Therapeutics
9 Meters Biopharma
ActoBio Therapeutics
In Chapter 6, on the basis of types, the Celiac Disease Treatment Pipeline Drug Evaluation market from 2015 to 2025 is primarily split into:
Oral
Parenteral
In Chapter 7, on the basis of applications, the Celiac Disease Treatment Pipeline Drug Evaluation market from 2015 to 2025 covers:
Preclinical
Phase 1
Phase 2
Phase 3
Phase 4
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Table of Content
1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Celiac Disease Treatment Pipeline Drug Evaluation Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis
2. Market Dynamics
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact
3 Associated Industry Assessment
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain
4 Market Competitive Landscape
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans
5 Analysis of Leading Companies
5.1 Selecta Biosciences
5.1.1 Selecta Biosciences Company Profile
5.1.2 Selecta Biosciences Business Overview
5.1.3 Selecta Biosciences Celiac Disease Treatment Pipeline Drug Evaluation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Selecta Biosciences Celiac Disease Treatment Pipeline Drug Evaluation Products Introduction
5.2 Takeda Pharmaceuticals (PvP Biologics)
5.2.1 Takeda Pharmaceuticals (PvP Biologics) Company Profile
5.2.2 Takeda Pharmaceuticals (PvP Biologics) Business Overview
5.2.3 Takeda Pharmaceuticals (PvP Biologics) Celiac Disease Treatment Pipeline Drug Evaluation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 Takeda Pharmaceuticals (PvP Biologics) Celiac Disease Treatment Pipeline Drug Evaluation Products Introduction
5.3 BioLineRx
5.3.1 BioLineRx Company Profile
5.3.2 BioLineRx Business Overview
5.3.3 BioLineRx Celiac Disease Treatment Pipeline Drug Evaluation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 BioLineRx Celiac Disease Treatment Pipeline Drug Evaluation Products Introduction
5.4 ImmunogenX
5.4.1 ImmunogenX Company Profile
5.4.2 ImmunogenX Business Overview
5.4.3 ImmunogenX Celiac Disease Treatment Pipeline Drug Evaluation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 ImmunogenX Celiac Disease Treatment Pipeline Drug Evaluation Products Introduction
5.5 Calypso Biotech
5.5.1 Calypso Biotech Company Profile
5.5.2 Calypso Biotech Business Overview
5.5.3 Calypso Biotech Celiac Disease Treatment Pipeline Drug Evaluation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 Calypso Biotech Celiac Disease Treatment Pipeline Drug Evaluation Products Introduction
5.6 ImmusanT
5.6.1 ImmusanT Company Profile
5.6.2 ImmusanT Business Overview
5.6.3 ImmusanT Celiac Disease Treatment Pipeline Drug Evaluation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 ImmusanT Celiac Disease Treatment Pipeline Drug Evaluation Products Introduction
5.7 Amgen
5.7.1 Amgen Company Profile
5.7.2 Amgen Business Overview
5.7.3 Amgen Celiac Disease Treatment Pipeline Drug Evaluation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 Amgen Celiac Disease Treatment Pipeline Drug Evaluation Products Introduction
5.8 Sitari Pharma
5.8.1 Sitari Pharma Company Profile
5.8.2 Sitari Pharma Business Overview
5.8.3 Sitari Pharma Celiac Disease Treatment Pipeline Drug Evaluation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 Sitari Pharma Celiac Disease Treatment Pipeline Drug Evaluation Products Introduction
5.9 Mayo Clinic
5.9.1 Mayo Clinic Company Profile
5.9.2 Mayo Clinic Business Overview
5.9.3 Mayo Clinic Celiac Disease Treatment Pipeline Drug Evaluation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.9.4 Mayo Clinic Celiac Disease Treatment Pipeline Drug Evaluation Products Introduction
5.10 Innovate Biopharmaceuticals
5.10.1 Innovate Biopharmaceuticals Company Profile
5.10.2 Innovate Biopharmaceuticals Business Overview
5.10.3 Innovate Biopharmaceuticals Celiac Disease Treatment Pipeline Drug Evaluation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.10.4 Innovate Biopharmaceuticals Celiac Disease Treatment Pipeline Drug Evaluation Products Introduction
5.11 Provention Bio
5.11.1 Provention Bio Company Profile
5.11.2 Provention Bio Business Overview
5.11.3 Provention Bio Celiac Disease Treatment Pipeline Drug Evaluation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.11.4 Provention Bio Celiac Disease Treatment Pipeline Drug Evaluation Products Introduction
5.12 Zedira
5.12.1 Zedira Company Profile
5.12.2 Zedira Business Overview
5.12.3 Zedira Celiac Disease Treatment Pipeline Drug Evaluation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.12.4 Zedira Celiac Disease Treatment Pipeline Drug Evaluation Products Introduction
5.13 Anokion
5.13.1 Anokion Company Profile
5.13.2 Anokion Business Overview
5.13.3 Anokion Celiac Disease Treatment Pipeline Drug Evaluation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.13.4 Anokion Celiac Disease Treatment Pipeline Drug Evaluation Products Introduction
5.14 Bioniz Therapeutics
5.14.1 Bioniz Therapeutics Company Profile
5.14.2 Bioniz Therapeutics Business Overview
5.14.3 Bioniz Therapeutics Celiac Disease Treatment Pipeline Drug Evaluation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.14.4 Bioniz Therapeutics Celiac Disease Treatment Pipeline Drug Evaluation Products Introduction
5.15 9 Meters Biopharma
5.15.1 9 Meters Biopharma Company Profile
5.15.2 9 Meters Biopharma Business Overview
5.15.3 9 Meters Biopharma Celiac Disease Treatment Pipeline Drug Evaluation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.15.4 9 Meters Biopharma Celiac Disease Treatment Pipeline Drug Evaluation Products Introduction
5.16 ActoBio Therapeutics
5.16.1 ActoBio Therapeutics Company Profile
5.16.2 ActoBio Therapeutics Business Overview
5.16.3 ActoBio Therapeutics Celiac Disease Treatment Pipeline Drug Evaluation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.16.4 ActoBio Therapeutics Celiac Disease Treatment Pipeline Drug Evaluation Products Introduction
6 Market Analysis and Forecast, By Product Types
6.1 Global Celiac Disease Treatment Pipeline Drug Evaluation Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Celiac Disease Treatment Pipeline Drug Evaluation Sales and Market Share by Types (2015-2020)
6.1.2 Global Celiac Disease Treatment Pipeline Drug Evaluation Revenue and Market Share by Types (2015-2020)
6.1.3 Global Celiac Disease Treatment Pipeline Drug Evaluation Price by Types (2015-2020)
6.2 Global Celiac Disease Treatment Pipeline Drug Evaluation Market Forecast by Types (2020-2025)
6.2.1 Global Celiac Disease Treatment Pipeline Drug Evaluation Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Celiac Disease Treatment Pipeline Drug Evaluation Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Celiac Disease Treatment Pipeline Drug Evaluation Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Celiac Disease Treatment Pipeline Drug Evaluation Sales, Price and Growth Rate of Oral
6.3.2 Global Celiac Disease Treatment Pipeline Drug Evaluation Sales, Price and Growth Rate of Parenteral
6.4 Global Celiac Disease Treatment Pipeline Drug Evaluation Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 Oral Market Revenue and Sales Forecast (2020-2025)
6.4.2 Parenteral Market Revenue and Sales Forecast (2020-2025)
7 Market Analysis and Forecast, By Applications
7.1 Global Celiac Disease Treatment Pipeline Drug Evaluation Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global Celiac Disease Treatment Pipeline Drug Evaluation Sales and Market Share by Applications (2015-2020)
7.1.2 Global Celiac Disease Treatment Pipeline Drug Evaluation Revenue and Market Share by Applications (2015-2020)
7.2 Global Celiac Disease Treatment Pipeline Drug Evaluation Market Forecast by Applications (2020-2025)
7.2.1 Global Celiac Disease Treatment Pipeline Drug Evaluation Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global Celiac Disease Treatment Pipeline Drug Evaluation Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global Celiac Disease Treatment Pipeline Drug Evaluation Revenue, Sales and Growth Rate of Preclinical (2015-2020)
7.3.2 Global Celiac Disease Treatment Pipeline Drug Evaluation Revenue, Sales and Growth Rate of Phase 1 (2015-2020)
7.3.3 Global Celiac Disease Treatment Pipeline Drug Evaluation Revenue, Sales and Growth Rate of Phase 2 (2015-2020)
7.3.4 Global Celiac Disease Treatment Pipeline Drug Evaluation Revenue, Sales and Growth Rate of Phase 3 (2015-2020)
7.3.5 Global Celiac Disease Treatment Pipeline Drug Evaluation Revenue, Sales and Growth Rate of Phase 4 (2015-2020)
7.4 Global Celiac Disease Treatment Pipeline Drug Evaluation Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 Preclinical Market Revenue and Sales Forecast (2020-2025)
7.4.2 Phase 1 Market Revenue and Sales Forecast (2020-2025)
7.4.3 Phase 2 Market Revenue and Sales Forecast (2020-2025)
7.4.4 Phase 3 Market Revenue and Sales Forecast (2020-2025)
7.4.5 Phase 4 Market Revenue and Sales Forecast (2020-2025)
8 Market Analysis and Forecast, By Regions
8.1 Global Celiac Disease Treatment Pipeline Drug Evaluation Sales by Regions (2015-2020)
8.2 Global Celiac Disease Treatment Pipeline Drug Evaluation Market Revenue by Regions (2015-2020)
8.3 Global Celiac Disease Treatment Pipeline Drug Evaluation Market Forecast by Regions (2020-2025)
9 North America Celiac Disease Treatment Pipeline Drug Evaluation Market Analysis
9.1 Market Overview and Prospect Analysis
9.2 North America Celiac Disease Treatment Pipeline Drug Evaluation Market Sales and Growth Rate (2015-2020)
9.3 North America Celiac Disease Treatment Pipeline Drug Evaluation Market Revenue and Growth Rate (2015-2020)
9.4 North America Celiac Disease Treatment Pipeline Drug Evaluation Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Celiac Disease Treatment Pipeline Drug Evaluation Market Analysis by Country
9.6.1 U.S. Celiac Disease Treatment Pipeline Drug Evaluation Sales and Growth Rate
9.6.2 Canada Celiac Disease Treatment Pipeline Drug Evaluation Sales and Growth Rate
9.6.3 Mexico Celiac Disease Treatment Pipeline Drug Evaluation Sales and Growth Rate
10 Europe Celiac Disease Treatment Pipeline Drug Evaluation Market Analysis
10.1 Market Overview and Prospect Analysis
10.2 Europe Celiac Disease Treatment Pipeline Drug Evaluation Market Sales and Growth Rate (2015-2020)
10.3 Europe Celiac Disease Treatment Pipeline Drug Evaluation Market Revenue and Growth Rate (2015-2020)
10.4 Europe Celiac Disease Treatment Pipeline Drug Evaluation Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Celiac Disease Treatment Pipeline Drug Evaluation Market Analysis by Country
10.6.1 Germany Celiac Disease Treatment Pipeline Drug Evaluation Sales and Growth Rate
10.6.2 United Kingdom Celiac Disease Treatment Pipeline Drug Evaluation Sales and Growth Rate
10.6.3 France Celiac Disease Treatment Pipeline Drug Evaluation Sales and Growth Rate
10.6.4 Italy Celiac Disease Treatment Pipeline Drug Evaluation Sales and Growth Rate
10.6.5 Spain Celiac Disease Treatment Pipeline Drug Evaluation Sales and Growth Rate
10.6.6 Russia Celiac Disease Treatment Pipeline Drug Evaluation Sales and Growth Rate
11 Asia-Pacific Celiac Disease Treatment Pipeline Drug Evaluation Market Analysis
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Celiac Disease Treatment Pipeline Drug Evaluation Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Celiac Disease Treatment Pipeline Drug Evaluation Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Celiac Disease Treatment Pipeline Drug Evaluation Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Celiac Disease Treatment Pipeline Drug Evaluation Market Analysis by Country
11.6.1 China Celiac Disease Treatment Pipeline Drug Evaluation Sales and Growth Rate
11.6.2 Japan Celiac Disease Treatment Pipeline Drug Evaluation Sales and Growth Rate
11.6.3 South Korea Celiac Disease Treatment Pipeline Drug Evaluation Sales and Growth Rate
11.6.4 Australia Celiac Disease Treatment Pipeline Drug Evaluation Sales and Growth Rate
11.6.5 India Celiac Disease Treatment Pipeline Drug Evaluation Sales and Growth Rate
12 South America Celiac Disease Treatment Pipeline Drug Evaluation Market Analysis
12.1 Market Overview and Prospect Analysis
12.2 South America Celiac Disease Treatment Pipeline Drug Evaluation Market Sales and Growth Rate (2015-2020)
12.3 South America Celiac Disease Treatment Pipeline Drug Evaluation Market Revenue and Growth Rate (2015-2020)
12.4 South America Celiac Disease Treatment Pipeline Drug Evaluation Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Celiac Disease Treatment Pipeline Drug Evaluation Market Analysis by Country
12.6.1 Brazil Celiac Disease Treatment Pipeline Drug Evaluation Sales and Growth Rate
12.6.2 Argentina Celiac Disease Treatment Pipeline Drug Evaluation Sales and Growth Rate
12.6.3 Columbia Celiac Disease Treatment Pipeline Drug Evaluation Sales and Growth Rate
13 Middle East and Africa Celiac Disease Treatment Pipeline Drug Evaluation Market Analysis
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Celiac Disease Treatment Pipeline Drug Evaluation Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Celiac Disease Treatment Pipeline Drug Evaluation Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Celiac Disease Treatment Pipeline Drug Evaluation Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Celiac Disease Treatment Pipeline Drug Evaluation Market Analysis by Country
13.6.1 UAE Celiac Disease Treatment Pipeline Drug Evaluation Sales and Growth Rate
13.6.2 Egypt Celiac Disease Treatment Pipeline Drug Evaluation Sales and Growth Rate
13.6.3 South Africa Celiac Disease Treatment Pipeline Drug Evaluation Sales and Growth Rate
14 Conclusions and Recommendations
14.1 Key Market Findings and Prospects
14.2 Advice for Investors
15 Appendix
15.1 Methodology
15.2 Research Data Source
Speak to Our Industry Expert
Our Clients
.png)
Need Help?
Please fill form below:
Call Us
USA: +1(929)-450-2887
USA: +1(650)-666-4592
Email Us
Contact Us
99 WALL STREET #2124 NEW YORK, NY 10005